


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.15%
+6.47%
-7.42%
-25.29%
+0.03%
LFMD
LifeMD
$3.71
Strengths

Earnings are forecast to grow

Trading below its fair value
Chart
$6.17 (-39.87%)
$6.19 (-40.06%)
$13.75 (-73.02%)
$6.54 (-43.27%)
LFMD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

LFMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
LFMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
LFMD Street Sentiment is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is LFMD current stock price?
What are LFMD stock strengths?
What is LFMD Risk Level?
What is LFMD market cap and volume?
What is LFMD current Stock IQ?
Should I buy LFMD stock right now?
Is LFMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for LFMD?
What does a 'Strong Sell' rating mean for LFMD?
What factors influence LFMD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.15%
+6.47%
-7.42%
-25.29%
+0.03%
LFMD
LifeMD
Current Price
$3.71
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Chart
$6.17 (-39.87%)
$6.19 (-40.06%)
$13.75 (-73.02%)
$6.54 (-43.27%)
LFMD Analysts Opinion
LFMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
LFMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
LFMD Street Sentiment is unimpressive and have negative views on the near-term outlook
LFMD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
LFMD Latest Analysis
Keybanc Maintains LifeMD (LFMD) Overweight Recommendation. Fintel reports that on November 19 2025 Keybanc maintained coverage of LifeMD (NasdaqGM:LFMD) with a Overweight recommendation. Analyst Price Forecast Suggests 229.14% Upside
Thu Nov 20, 2025
HC Wainwright & Co. Maintains LifeMD (LFMD) Buy Recommendation. Fintel reports that on November 19 2025 HC Wainwright &. Co. maintained coverage of LifeMD (NasdaqGM:LFMD) with a Buy recommendation. Analyst Price Forecast Suggests 229.14% Upside
Thu Nov 20, 2025
Mizuho Maintains LifeMD (LFMD) Neutral Recommendation. Fintel reports that on November 19 2025 Mizuho maintained coverage of LifeMD (NasdaqGM:LFMD) with a Neutral recommendation. Analyst Price Forecast Suggests 229.14% Upside
Thu Nov 20, 2025
LifeMD Inc. (NASDAQ:LFMD) Q3 2025 Earnings Call Transcript. LifeMD Inc. (NASDAQ:LFMD) Q3 2025 Earnings Call Transcript November 17 2025 LifeMD Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS expectations were $-0.06. Operator: Good afternoon. Thank you for joining us today to discuss LifeMD’.s results for the third quarter ended September 30 2025. Joining the call today are Justin Schreiber Chairman and [….]
Wed Nov 19, 2025
B. Riley Securities Maintains LifeMD (LFMD) Buy Recommendation. Fintel reports that on November 18 2025 B. Riley Securities maintained coverage of LifeMD (NasdaqGM:LFMD) with a Buy recommendation. Analyst Price Forecast Suggests 177.64% Upside
Wed Nov 19, 2025
Lake Street Maintains LifeMD (LFMD) Buy Recommendation. Fintel reports that on November 18 2025 Lake Street maintained coverage of LifeMD (NasdaqGM:LFMD) with a Buy recommendation. Analyst Price Forecast Suggests 177.64% Upside
Wed Nov 19, 2025
BTIG Maintains LifeMD (LFMD) Buy Recommendation. Fintel reports that on November 18 2025 BTIG maintained coverage of LifeMD (NasdaqGM:LFMD) with a Buy recommendation. Analyst Price Forecast Suggests 177.64% Upside
Wed Nov 19, 2025
LifeMD outlines $192M-$193M 2025 revenue target amid margin shifts and expansion into womens and behavioral health.
Mon Nov 17, 2025
LifeMD Inc. (LFMD) Reports Q3 Loss Misses Revenue Estimates. LifeMD (LFMD) delivered earnings and revenue surprises of -66.67% and -3.42% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Mon Nov 17, 2025
LifeMD GAAP EPS of -$0.10 misses by $0.06 revenue of $60.2M misses by $1.93M.
Mon Nov 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
LFMD Stock trends
LFMD Stock performance
LFMD Stock analysis
LFMD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.